Filgrastim biosimilar(Blau Farmaceutica)

非格司亭生物类似药（Blau Farmaceutica）

Report date: 2023/03/30 20:00:23

Base Information

Drug NameFilgrastim biosimilar(Blau Farmaceutica)

Drug Alias NamerhG-CSF (Blau Farmaceutica)非格司亭生物仿制药（Blau Farmaceutica）Recombinant human granulocyte macrophage colony stimulating factor (Blau Farmaceutica)重组人粒细胞刺激因子（Blau Farmaceutica）Filgrastine (Blau Farmaceutica)

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesBlau Farmaceutica Sa

China Registration ClassN/A

Develop Information

Active CompaniesBlau Farmaceutica Sa

Inactive CompaniesN/A

Active IndicationsNeutropenia

Inactive IndicationsN/A

Other Information

ATC CodeN/A